{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:16:06Z","timestamp":1761894966940},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.reuma.2009.07.004","type":"journal-article","created":{"date-parts":[[2009,9,26]],"date-time":"2009-09-26T09:02:34Z","timestamp":1253955754000},"page":"35-39","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S3","title":["Tratamiento y pron\u00f3stico"],"prefix":"10.1016","volume":"5","author":[{"given":"Lu\u00eds J.","family":"Catoggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique R.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier E.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2009.07.004_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis","volume":"92","author":"Bunch","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reuma.2009.07.004_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"30","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2009.07.004_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: A longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reuma.2009.07.004_bib4","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"Myositis: Immunologic contributions to understanding cause, pathogenesis, and therapy","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reuma.2009.07.004_bib6","first-page":"545","article-title":"Course of dermatomyositis polymyositis: Comparison of untreated and cortisone-treated patients","volume":"43","author":"Winkelmann","year":"1968","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.reuma.2009.07.004_bib7","doi-asserted-by":"crossref","unstructured":"Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971\u201382.","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"10.1016\/j.reuma.2009.07.004_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00002281-200011000-00003","article-title":"Current approach to the treatment of polymyositis and dermatomyositis","volume":"12","author":"Oddis","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib9","first-page":"1148","article-title":"A metanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis","volume":"26","author":"Homik","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00124743-199504000-00007","article-title":"The use of low-dose oral methotrexate in the treatment of polymyositis and dermatomyositis","volume":"1","author":"Newman","year":"1995","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0190-9622(95)91455-2","article-title":"Treatment of dermatomyositis with methotrexate","volume":"32","author":"Zieglschmid Adams","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib12","first-page":"90","article-title":"Caracter\u00edsticas cl\u00ednico-serol\u00f3gicas de 34 pacientes argentinos con dermato-polimiositis","volume":"4","author":"Imamura","year":"1993","journal-title":"Rev Argentina Reumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/096120339300200604","article-title":"Hydroxychloroquine, dosage parameters and retinopathy","volume":"2","author":"Spalton","year":"1993","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2009.07.004_bib14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2005.045898","article-title":"Rituximab in the treatment of antisynthetase syndrome","volume":"65","author":"Brulhart","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2009.07.004_bib15","first-page":"1021","article-title":"Rituximab as therapy for refractory polymyositis and dermatomyositis","volume":"33","author":"Noss","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib16","first-page":"2855","article-title":"Cyclosporin A in the treatment of refractory adult polymyositis\/dermatomyositis: Population based experience in 6 patients and literature review","volume":"27","author":"Qushmaq","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib17","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory polymyositis with interstitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.reuma.2009.07.004_bib18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/rheumatology\/kel336","article-title":"Mycophenolate mofetil treatment in resistant myositis","volume":"46","author":"Pisoni","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reuma.2009.07.004_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.07.004_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000070852","article-title":"Successful treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: Preliminary observations","volume":"50","author":"Hengstman","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.reuma.2009.07.004_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/art.1780370519","article-title":"Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis","volume":"37","author":"Park","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.07.004_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780280606","article-title":"Cricopharyngeal obstruction in inflammatory myopathy (polymyositis\/dermatomyositis): Report of three cases and review of the literature","volume":"28","author":"Kagen","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2009.07.004_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2169\/internalmedicine.38.733","article-title":"Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis","volume":"38","author":"Yoshida","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.reuma.2009.07.004_bib24","first-page":"1327","article-title":"The dilemma of treating patients with inclusion body myositis","volume":"19","author":"Wortmann","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2009.07.004_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.56.3.323","article-title":"A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM","volume":"56","author":"Dalakas","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.reuma.2009.07.004_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.reuma.2009.07.004_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004150050005","article-title":"High-dose immunoglobulin therapy in sporadic inclusion body myositis: A double-blind, placebo-controlled study","volume":"247","author":"Walter","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.reuma.2009.07.004_bib28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.43.5.876","article-title":"Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin","volume":"43","author":"Soueidan","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.reuma.2009.07.004_bib29","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1212\/WNL.44.8.1516","article-title":"Inclusion body myositis: Treatment with intravenous immunoglobulin","volume":"44","author":"Amato","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.reuma.2009.07.004_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/WNL.58.2.326","article-title":"Intravenous immunoglobulin for dysphagia of inclusion body myositis","volume":"58","author":"Cherin","year":"2002","journal-title":"Neurology"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X09001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T21:35:41Z","timestamp":1558560941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X09001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":30,"alternative-id":["S1699258X09001910"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2009.07.004","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}